Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cisplatin - Privo Technologies

Next Previous
Search
Drug Profile

Cisplatin - Privo Technologies

Alternative Names: Cisplatin transmucosal patch - Privo Technologies; Cisplatin Transmucosal System; Intratumoural cisplatin injectable - Privo Technologies; PRV 111; PRV-131; PRV-211; PRV-311; PRV111 patch; PRV211 patch

Latest Information Update: 12 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Privo Technologies
  • Class Antineoplastics; Platinum complexes; Small molecules
  • Mechanism of Action DNA cross linking agents; DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Anal cancer; Mouth neoplasm; Carcinoma
  • New Molecular Entity No

Highest Development Phases

  • Phase II Squamous cell cancer
  • Preclinical Cervical cancer; Colorectal cancer; Head and neck cancer; Lung cancer

Most Recent Events

  • 12 Mar 2025 Preclinical trials in Cervical cancer in USA (unspecified route) before March 2025 (Privo Technologies pipeline, March 2025)
  • 14 Jun 2024 Preclinical trials in Head and neck cancer in USA (Intratumoural) prior to June 2024 (Privo Technologies pipeline, June 2024)
  • 14 Jun 2024 Preclinical trials in Lung cancer in USA (Intratumoural) prior to June 2024 (Privo Technologies pipeline, June 2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top